|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
CA2746470A1
(en)
|
2009-01-06 |
2010-07-15 |
Raymond-David Pridmore |
Processing of macronutrients
|
|
TWI541021B
(zh)
|
2009-03-05 |
2016-07-11 |
艾伯維有限公司 |
Ｉｌ－１７結合蛋白
|
|
US10087408B2
(en)
|
2010-07-07 |
2018-10-02 |
The University Of British Columbia |
System and method for microfluidic cell culture
|
|
US9188593B2
(en)
|
2010-07-16 |
2015-11-17 |
The University Of British Columbia |
Methods for assaying cellular binding interactions
|
|
JPWO2012176779A1
(ja)
*
|
2011-06-20 |
2015-02-23 |
協和発酵キリン株式会社 |
抗ｅｒｂＢ３抗体
|
|
BR112015027313A2
(pt)
|
2013-04-29 |
2017-09-26 |
Teva Pharmaceuticals Australia Pty Ltd |
anticorpos anti-cd38 e fusões ao interferon alfa-2b atenuado
|
|
WO2015033223A2
(en)
|
2013-09-03 |
2015-03-12 |
Novimmune S.A. |
Readily isolated bispecific binding molecules with native format having mutated constant regions
|
|
CN105218669A
(zh)
|
2014-06-10 |
2016-01-06 |
河北翰林生物科技有限公司 |
制备抗人r47h-trem2突变体的人单克隆抗体的方法
|
|
CA2955086A1
(en)
|
2014-08-08 |
2016-02-11 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
CA2961950A1
(en)
|
2014-09-28 |
2016-03-31 |
The Regents Of The University Of California |
Modulation of stimulatory and non-stimulatory myeloid cells
|
|
EP3973980A1
(en)
*
|
2015-03-31 |
2022-03-30 |
F. Hoffmann-La Roche AG |
Antigen binding molecules comprising a trimeric tnf family ligand
|
|
WO2017058866A1
(en)
*
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
|
US20190330335A1
(en)
*
|
2015-10-06 |
2019-10-31 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
WO2017147509A1
(en)
|
2016-02-25 |
2017-08-31 |
Marco Colonna |
Compositions comprising trem2 and methods of use thereof
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
CN109641961A
(zh)
|
2016-07-22 |
2019-04-16 |
德国神经退行性疾病研究中心 |
Trem2切割调节剂及其用途
|
|
CA3048224A1
(en)
|
2016-12-23 |
2018-06-28 |
Bluefin Biomedicine, Inc. |
Anti-sez6l2 antibodies and antibody drug conjugates
|
|
EP3570883A2
(en)
|
2017-01-17 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
|
SG11201907422RA
(en)
|
2017-02-17 |
2019-09-27 |
Denali Therapeutics Inc |
Anti-tau antibodies and methods of use thereof
|
|
CN110506055A
(zh)
|
2017-02-17 |
2019-11-26 |
戴纳立制药公司 |
工程改造的转铁蛋白受体结合多肽
|
|
US10457717B2
(en)
|
2017-02-17 |
2019-10-29 |
Denali Therapeutics Inc. |
Engineered polypeptides
|
|
JOP20190248A1
(ar)
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
BR112020001060A2
(pt)
|
2017-07-27 |
2020-07-14 |
Novartis Ag |
variantes de trem2 resistentes a shedase
|
|
DK3601358T5
(da)
|
2017-08-03 |
2024-09-02 |
Alector Llc |
Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf
|
|
EP3665194A4
(en)
|
2017-08-10 |
2021-07-07 |
Denali Therapeutics Inc. |
AFFINITY BASED METHODS OF USING TRANSFERRIN RECEPTOR BINDING PROTEINS
|
|
WO2019055841A1
(en)
|
2017-09-14 |
2019-03-21 |
Denali Therapeutics Inc. |
ANTI-TREM2 ANTIBODIES AND METHODS OF USE
|
|
CR20200129A
(es)
|
2017-10-02 |
2020-08-22 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
|
|
US20210186917A1
(en)
|
2017-10-17 |
2021-06-24 |
The Translational Genomics Research Institute |
Trem2 agonists for the stimulation of microglia and methods of identification
|
|
WO2019094608A1
(en)
|
2017-11-08 |
2019-05-16 |
Denali Therapeutics Inc. |
Anti-bace1 antibodies and methods of use thereof
|
|
AU2018383709B2
(en)
|
2017-12-12 |
2025-09-11 |
Pionyr Immunotherapeutics, Inc. |
Anti-TREM2 antibodies and related methods
|
|
TW201934573A
(zh)
|
2018-01-10 |
2019-09-01 |
美商戴納立製藥公司 |
轉鐵蛋白受體結合性多肽及其用途
|
|
WO2019246071A1
(en)
|
2018-06-18 |
2019-12-26 |
Denali Therapeutics Inc. |
Fusion proteins comprising progranulin
|
|
GB201811404D0
(en)
|
2018-07-12 |
2018-08-29 |
F Star Beta Ltd |
Anti-CD137 Antibodies
|
|
WO2020037150A2
(en)
|
2018-08-16 |
2020-02-20 |
Denali Therapeutics Inc. |
Engineered bispecific proteins
|
|
JP2021534220A
(ja)
|
2018-08-22 |
2021-12-09 |
デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. |
抗ｈｅｒ２ポリペプチド及びそれらの使用の方法
|
|
CA3111569A1
(en)
|
2018-09-11 |
2020-03-19 |
Washington University |
Anti-trem-2 agonist antibodies
|
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
|
KR102156165B1
(ko)
|
2018-10-29 |
2020-09-15 |
재단법인대구경북과학기술원 |
인간 ｔｒｅｍ２ 세포막 단백질에 대한 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
|
|
CA3120970A1
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
US20220025065A1
(en)
|
2018-12-10 |
2022-01-27 |
Denali Therapeutics Inc. |
Lysosomal storage disorder biomarkers and methods of use thereof
|
|
US12351629B2
(en)
|
2018-12-10 |
2025-07-08 |
Mor Research Applications Ltd. |
TREM2 antibodies and uses thereof
|
|
KR20210104079A
(ko)
|
2018-12-11 |
2021-08-24 |
파이오니어 임뮤노테라퓨틱스, 인코퍼레이티드 |
항-trem2 항체를 사용하는 방법
|
|
BR112021015656A2
(pt)
|
2019-02-20 |
2021-10-05 |
Denali Therapeutics Inc. |
Anticorpos anti-trem2 e métodos de uso dos mesmos
|
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
|
CA3134538A1
(en)
|
2019-04-03 |
2020-10-08 |
Denali Therapeutics Inc. |
Formulations of protein molecules comprising iduronate 2-sulfatase
|
|
PH12022551598A1
(en)
|
2019-12-23 |
2023-11-20 |
Denali Therapeutics Inc |
Progranulin variants
|
|
JP2023512450A
(ja)
|
2020-01-13 |
2023-03-27 |
デナリ セラピューティクス インコーポレイテッド |
抗ｔｒｅｍ２抗体及びその使用方法
|
|
WO2021146256A1
(en)
|
2020-01-13 |
2021-07-22 |
Denali Therapeutics Inc. |
Anti-trem2 antibodies and methods of use thereof
|
|
WO2021158986A1
(en)
|
2020-02-07 |
2021-08-12 |
Denali Therapeutics Inc. |
Methods for the treatment of hunter syndrome
|
|
AU2021224200A1
(en)
|
2020-02-19 |
2022-09-08 |
Denali Therapeutics Inc. |
Engineered anti-HER2 bispecific proteins
|
|
EP4229192A1
(en)
|
2020-10-14 |
2023-08-23 |
Denali Therapeutics Inc. |
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof
|